메뉴 건너뛰기




Volumn 98, Issue 10, 2005, Pages 979-983

Intra-individual variability of the platelet anti-aggregation effect of aspirin in coronary patients;Variabilité intra-individuelle de l'effet antiagrégant plaquettaire de l'aspirine chez le coronarien

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

EID: 33644807963     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (4)

References (25)
  • 1
    • 0038604480 scopus 로고    scopus 로고
    • Aspirin and hemostasis
    • Samama MM, Elalamy I. Aspirin and hemostasis. Rev Med Interne 2000;21(Suppl 1):27-34.
    • (2000) Rev Med Interne , vol.21 , Issue.SUPPL. 1 , pp. 27-34
    • Samama, M.M.1    Elalamy, I.2
  • 2
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 3
    • 0027447701 scopus 로고
    • Aspirin response ana failure in cerebral infarction
    • Helgason CM, Tortorice KL, Winkler SR, et al. Aspirin response ana failure in cerebral infarction. Stroke 1993;24:345-50.
    • (1993) Stroke , vol.24 , pp. 345-350
    • Helgason, C.M.1    Tortorice, K.L.2    Winkler, S.R.3
  • 4
    • 0035421783 scopus 로고    scopus 로고
    • Profile and prevalence of aspirin resistance in patients with cardiovascular disease
    • Gum PA, Kottke-Marchant K, Poggio ED, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001;88:230-5.
    • (2001) Am J Cardiol , vol.88 , pp. 230-235
    • Gum, P.A.1    Kottke-Marchant, K.2    Poggio, E.D.3
  • 5
    • 18744402157 scopus 로고    scopus 로고
    • Aspirin resistance after coronary artery bypass grafting
    • Zimmermann N, Kienzle P, Weber AA, et al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2001;121:982-4.
    • (2001) J Thorac Cardiovasc Surg , vol.121 , pp. 982-984
    • Zimmermann, N.1    Kienzle, P.2    Weber, A.A.3
  • 6
    • 1542708471 scopus 로고    scopus 로고
    • Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment
    • Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004;43:1122-6.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 1122-1126
    • Chen, W.H.1    Lee, P.Y.2    Ng, W.3    Tse, H.F.4    Lau, C.P.5
  • 7
    • 2342619016 scopus 로고    scopus 로고
    • Aspirin resistance in diabetic patients
    • de Gaetano G. Aspirin resistance in diabetic patients. Diabetes Care 2004;27:1244-5.
    • (2004) Diabetes Care , vol.27 , pp. 1244-1245
    • de Gaetano, G.1
  • 8
    • 1942501813 scopus 로고    scopus 로고
    • Actualités sur la résistance à l'aspirine en 2003
    • Christiaens L, Macchi L. Actualités sur la résistance à l'aspirine en 2003. Arch Mal Cœur 2004;97:320-6.
    • (2004) Arch Mal Cœur , vol.97 , pp. 320-326
    • Christiaens, L.1    Macchi, L.2
  • 10
    • 0037046196 scopus 로고    scopus 로고
    • Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events
    • Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 2002; 105:1650-5.
    • (2002) Circulation , vol.105 , pp. 1650-1655
    • Eikelboom, J.W.1    Hirsh, J.2    Weitz, J.I.3    Johnston, M.4    Yi, Q.5    Yusuf, S.6
  • 11
    • 0037454168 scopus 로고    scopus 로고
    • A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease
    • Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol 2003;41:901-5.
    • (2003) J Am Coll Cardiol , vol.41 , pp. 901-905
    • Gum, P.A.1    Kottke-Marchant, K.2    Welsh, P.A.3    White, J.4    Topol, E.J.5
  • 12
    • 0025804692 scopus 로고
    • Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease
    • Berglund U, Wallentin L. Persistent inhibition of platelet function during long-term treatment with 75 mg acetylsalicylic acid daily in men with unstable coronary artery disease. Eur Heart J 1991;12:428-33.
    • (1991) Eur Heart J , vol.12 , pp. 428-433
    • Berglund, U.1    Wallentin, L.2
  • 13
    • 0027970934 scopus 로고
    • Development of aspirin resistance in persons with previous ischemic stroke
    • Helgason CM, Bolin KM, Hoff JA, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke 1994;25:2331-6.
    • (1994) Stroke , vol.25 , pp. 2331-2336
    • Helgason, C.M.1    Bolin, K.M.2    Hoff, J.A.3
  • 15
    • 0036826025 scopus 로고    scopus 로고
    • Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
    • Andersen K, Hurlen M, Arnesen H, Seljeflot I. Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 2002;108:37-42.
    • (2002) Thromb Res , vol.108 , pp. 37-42
    • Andersen, K.1    Hurlen, M.2    Arnesen, H.3    Seljeflot, I.4
  • 16
    • 0346433909 scopus 로고    scopus 로고
    • In vitro aspirin resistance detected by PFA-100 closure time: Pivotal role of plasma von Willebrand factor
    • Chakroun T, Gerotziafas G, Robert F, et al. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004; 124:80-5.
    • (2004) Br J Haematol , vol.124 , pp. 80-85
    • Chakroun, T.1    Gerotziafas, G.2    Robert, F.3
  • 17
    • 0028934985 scopus 로고
    • Individual variation in the effects of ASA on platelet function: Implications for the use of ASA clinically
    • Buchanan MR, Brister SJ. Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically. Can J Cardiol 1995;11:221-7.
    • (1995) Can J Cardiol , vol.11 , pp. 221-227
    • Buchanan, M.R.1    Brister, S.J.2
  • 18
    • 3543005314 scopus 로고    scopus 로고
    • Platelet inhibition by aspirin is diminished in patients during carotid surgery: A form of transient aspirin resistance?
    • Payne DA, Jones CI, Hayes PD, Webster SE, Ross Naylor A, Goodall AH. Platelet inhibition by aspirin is diminished in patients during carotid surgery: a form of transient aspirin resistance? Thromb Haemost 2004;92:89-96.
    • (2004) Thromb Haemost , vol.92 , pp. 89-96
    • Payne, D.A.1    Jones, C.I.2    Hayes, P.D.3    Webster, S.E.4    Ross Naylor, A.5    Goodall, A.H.6
  • 19
    • 0141851094 scopus 로고    scopus 로고
    • Aspirin resistance: Definition, mechanisms and clinical read-outs
    • Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 2003;1:1710-3.
    • (2003) J Thromb Haemost , vol.1 , pp. 1710-1713
    • Patrono, C.1
  • 20
    • 0037442182 scopus 로고    scopus 로고
    • Effect of ibuprofen on cardioprotective effect of aspirin
    • MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003;361:573-4.
    • (2003) Lancet , vol.361 , pp. 573-574
    • MacDonald, T.M.1    Wei, L.2
  • 21
    • 0036878918 scopus 로고    scopus 로고
    • Resistance to aspirin in vitro at rest and during exercice in patients with angiographically proven coronary artery disease
    • Christiaens L, Macchi L, Herpin D, et al. Resistance to aspirin in vitro at rest and during exercice in patients with angiographically proven coronary artery disease. Thromb Res 2003;108:115-9.
    • (2003) Thromb Res , vol.108 , pp. 115-119
    • Christiaens, L.1    Macchi, L.2    Herpin, D.3
  • 22
    • 0042735242 scopus 로고    scopus 로고
    • Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms
    • Macchi L, Christiaens L, Brabant S, et al. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms. J Am Coll Cardiol 2003;42:1115-9.
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1115-1119
    • Macchi, L.1    Christiaens, L.2    Brabant, S.3
  • 23
    • 0037046174 scopus 로고    scopus 로고
    • Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?
    • Halushka MK, Halushka PV. Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? Circulation 2002;105:1620-2.
    • (2002) Circulation , vol.105 , pp. 1620-1622
    • Halushka, M.K.1    Halushka, P.V.2
  • 24
    • 0038649988 scopus 로고    scopus 로고
    • Clopidogrel for coronary stenting: Response variability, drug resistance, and the effect of pretreatment platelet reactivity
    • Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003;107:2908-13.
    • (2003) Circulation , vol.107 , pp. 2908-2913
    • Gurbel, P.A.1    Bliden, K.P.2    Hiatt, B.L.3    O'Connor, C.M.4
  • 25
    • 0036379817 scopus 로고    scopus 로고
    • Individual variations of platelet inhibition after loading doses of clopidogrel
    • Jaremo P, Lindahl TL, Fransson SG, Richter A. Individual variations of platelet inhibition after loading doses of clopidogrel. J Intern Med 2002;252:233-8.
    • (2002) J Intern Med , vol.252 , pp. 233-238
    • Jaremo, P.1    Lindahl, T.L.2    Fransson, S.G.3    Richter, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.